XTL Biopharmaceuticals Ltd.
XTLB
$2.92
$0.031.04%
NASDAQ
| 12/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -93.35% | -43.02% | -33.45% | -49.72% | 3.01% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 75.86% | 8.47% | -40.77% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 91.49% | 327.27% | -- | -- | -- |
| Total Current Assets | -87.61% | -34.51% | -19.31% | -49.46% | -52.85% |
|
|
|||||
| Total Current Assets | -87.61% | -34.51% | -19.31% | -49.46% | -52.85% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 904.21% | 0.00% | 0.00% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -98.06% | 252.43% | -16.77% | -45.62% | -49.83% |
|
|
|||||
| Total Accounts Payable | -91.19% | 22,600.00% | 1.23% | 5.88% | -- |
| Total Accrued Expenses | -75.96% | 165.85% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -79.26% | -- | -- | -- | -- |
| Total Other Current Liabilities | -79.26% | -- | -- | -- | -- |
| Total Current Liabilities | -80.97% | 971.36% | 1.23% | 5.88% | -7.31% |
|
|
|||||
| Total Current Liabilities | -80.97% | 971.36% | 1.23% | 5.88% | -7.31% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -86.52% | 1,412.14% | 1.23% | 5.88% | -68.98% |
|
|
|||||
| Common Stock & APIC | 0.57% | 2.48% | 0.00% | 0.00% | 2,645.48% |
| Retained Earnings | -4.17% | -0.48% | -0.31% | -1.44% | -- |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Common Equity | -104.67% | 144.82% | -17.84% | -47.28% | -47.28% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -104.67% | 144.82% | -17.84% | -47.28% | -47.28% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -104.67% | 144.82% | -17.84% | -47.28% | -47.28% |
|
|
|||||